Table 1.
Clinical statistics of the study population.
| Dippers, | Non-dippers, | P | |
|---|---|---|---|
| n = 111 | n = 179 | ||
| Age (years) | 49.0 ± 12.3 | 52.5 ± 12.7* | 0.021 |
| Sex (n, %) males | 56 (50.5%) | 106 (59.2%) | 0.147 |
| Smoker (%) | 28 (25.2%) | 63 (35.2%) | 0.091 |
| DM (%) | 30 (27.0%) | 58 (32.4%) | 0.360 |
| HT duration(years) | 5.0 (1.6, 10.0) | 5.0 (2.0, 10.0) | 0.380 |
| eGFR (ml/min/1.73 m2) | 116.3 ± 27.3 | 107.4 ± 23.7 | 0.004 |
| BMI (kg/m2) | 27.0 ± 3.7 | 27.1 ± 3.6 | 0.881 |
| FPG (mmol/L) | 5.4 (4.7, 6.3) | 5.2 (4.6, 6.0) | 0.326 |
| HbA1c (%) | 5.9 (5.5, 6.4) | 5.9 (5.6, 6.4) | 0.475 |
| TC (mmol/L) | 4.6 ± 0.9 | 4.8 ± 1.1 | 0.268 |
| TG (mmol/L) | 1.5 (1.1, 2.2) | 1.5 (1.0, 2.1) | 0.689 |
| LDL-C (mmol/L) | 2.7 ± 0.7 | 2.8 ± 0.8 | 0.491 |
| HDL-C (mmol/L) | 1.2 ± 0.3 | 1.2 ± 0.3 | 0.757 |
| BNP (ng/L) | 16.7 (9.3, 42.2) | 24.4 (11.0, 46.9) | 0.234 |
| Hs-cTnI (μg/L) | 0.01 (0.01, 0.01) | 0.01 (0.00, 0.01) | 0.841 |
| Medications | |||
| CCB (%) | 72 (64.9%) | 115 (64.2%) | 1.000 |
| ACEI/ARB/ARNI (%) | 47 (42.3%) | 76 (42.5%) | 1.000 |
| β-blockers (%) | 40 (36.0%) | 45 (25.1%) | 0.063 |
| Diuretics (%) | 11 (9.9%) | 23 (12.8%) | 0.574 |
DM, diabetes mellitus; HT duration, hypertension duration; BMI, body mass index; FPG, fasting plasma glucose; HbA1c, glycosylated haemoglobin; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; BNP, B-type natriuretic peptide; Hs-cTnI, High-sensitive cardiac troponin I; CCB, calcium antagonists; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ARNI, Angiotensin receptor-neprilysin inhibitor.